Artwork

内容由EMJ提供。所有播客内容(包括剧集、图形和播客描述)均由 EMJ 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Episode 225: Behind the Breakthroughs: Tackling Vasculitis and Emerging Inflammatory Diseases

30:33
 
分享
 

Manage episode 446345508 series 3412919
内容由EMJ提供。所有播客内容(包括剧集、图形和播客描述)均由 EMJ 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital. Stone discusses his groundbreaking work in systemic vasculitis, including granulomatosis with polyangiitis and ANCA-associated vasculitis. He also shares insights into the emerging field of IgG4-related disease and the exciting possibility of the first approved therapy for this condition. Alongside, he delves into his efforts to minimise glucocorticoid toxicity and his work through the IgG4ward! Foundation.

Timestamps:

(00:30) – Introduction

(04:00) – Stone’s journey into rheumatology

(07:28) – WEGET trial

(10:30) – Developments in IgG4-related disease and the path to therapy approval

(15:52) – Key advancements in the treatment of granulomatosis with polyangiitis

(18:04) – Glucocorticoid toxicity and the Glucocorticoid Toxicity Index (GTI)

(20:34) – The IgG4ward! Foundation

(23:48) – Two Pearls and a Myth

(26:45) – Stone’s three wishes for rheumatology

  continue reading

200集单集

Artwork
icon分享
 
Manage episode 446345508 series 3412919
内容由EMJ提供。所有播客内容(包括剧集、图形和播客描述)均由 EMJ 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

In this episode, Jonathan is joined by John H. Stone, Professor of Medicine at Harvard Medical School and The Edward A. Fox Chair in Medicine at Massachusetts General Hospital. Stone discusses his groundbreaking work in systemic vasculitis, including granulomatosis with polyangiitis and ANCA-associated vasculitis. He also shares insights into the emerging field of IgG4-related disease and the exciting possibility of the first approved therapy for this condition. Alongside, he delves into his efforts to minimise glucocorticoid toxicity and his work through the IgG4ward! Foundation.

Timestamps:

(00:30) – Introduction

(04:00) – Stone’s journey into rheumatology

(07:28) – WEGET trial

(10:30) – Developments in IgG4-related disease and the path to therapy approval

(15:52) – Key advancements in the treatment of granulomatosis with polyangiitis

(18:04) – Glucocorticoid toxicity and the Glucocorticoid Toxicity Index (GTI)

(20:34) – The IgG4ward! Foundation

(23:48) – Two Pearls and a Myth

(26:45) – Stone’s three wishes for rheumatology

  continue reading

200集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南

边探索边听这个节目
播放